galectin 3 in serum/plasma
Jump to navigation
Jump to search
Reference interval
- < 17.8 ng/mL
Clinical significance
- associated with higher mortality in both acute heart failure & chronic heart failure
- marker of myocardial remodelling in patients with heart failure
Additional terms
References
- ↑ van Kimmenade RR et al Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure. J Am Coll Cardiol. 2006;48(6):1217-24 PMID: https://www.ncbi.nlm.nih.gov/pubmed/16979009
- ↑ Lin YH et al The relationship between serum galectin-3 and serum markers of cardiac extracellular matrix turnover in heart failure patients. Clin Chim Acta. 2009 Nov;409(1-2):96-9. PMID: https://www.ncbi.nlm.nih.gov/pubmed/19747906
- ↑ Lok DJ et al Galectin-3 is an independent marker for ventricular remodeling and mortality in patients with chronic heart failure. Clin Res Cardiol. 2012 Aug 12 PMID: https://www.ncbi.nlm.nih.gov/pubmed/22886030
- ↑ Galectin-3 in Chronic Heart Failure http://www.galectin-3.com/home/galectin-3-in-heart-failure/